Introduction {#S1}
============

Atherosclerotic cardiovascular disease is the leading cause of death worldwide ([@B24]). Atherosclerosis is the pathological basis of peripheral vascular, coronary, and cerebrovascular disease ([@B53]). Numerous traditional risk factors for atherosclerosis have been reported, including genetic predisposition, aging, hypertension, diabetes, obesity and smoking, and exposure to these risk factors plays important roles in the development of atherosclerosis. Recently, a number of novel atherosclerosis risk factors have been identified ([@B18]). These novel risk factors are expected to provide optimal diagnostic and therapeutic strategies for reducing cardiovascular and cerebrovascular events in patients.

Obstructive sleep apnea (OSA), characterized by recurrent pharyngeal collapses during sleep ([@B37]), increases linearly with age and is considered a major public health issue affecting 3--7% of the middle-aged population (30--70 years) ([@B13]; [@B57]). Several studies have shown that OSA is an independent risk factor for cardiovascular disease ([@B44]; [@B5]; [@B40]), resulting in hypertension ([@B36]), stroke ([@B55]), cardiac events ([@B47]), heart failure ([@B32]), arrhythmia ([@B45]), and sudden death in the night ([@B19]). Many clinical and research studies have provided evidence for a correlation between OSA and atherosclerosis ([@B49]) and demonstrated that OSA changes the progression and outcomes of atherosclerosis. OSA is associated with increased carotid intima-media thickness (IMT) and plaque occurrence (early atherosclerotic lesions), independent of cardiovascular risk factors or cardiovascular diseases ([@B2]). OSA is also independently associated with arterial stiffness ([@B10], [@B11]), which is a strong predictor of late cardiovascular event. Although evidence supporting the aggravation of atherosclerosis by OSA is relatively strong, relatively little is known about the underlying molecular mechanisms linking OSA to atherosclerosis.

A prominent feature of OSA pathophysiology is chronic intermittent hypoxia (CIH), which is long-term exposure to repeated episodes of reoxygenation following hypoxia induced by airflow obstruction during sleep ([@B42]; [@B8]). CIH is a major underlying culprit for OSA-induced cardiovascular and cerebrovascular complications ([@B34]; [@B40]). CIH promotes atherosclerotic plaque formation in ApoE-deficient mice fed a normal chow diet ([@B14]) or high cholesterol diet ([@B29]). In addition, continuous positive airway pressure (CPAP) therapy for OSA patients ameliorates atherosclerosis by reducing IMT and carotid to femoral artery pulse wave velocity (CF-PWV) ([@B9]). The core pathological manifestations of OSA depend on the strong correlation between CIH and atherosclerosis, and CIH accelerates the development of atherosclerosis. The roles and mechanisms of CIH in the development of atherosclerosis are still unknown.

Long non-coding RNAs (lncRNAs) are non-protein-coding RNAs \> 200 nucleotides in length characterized by RNA polymerase II processing, a 5′ cap, and 3′ polyadenylation ([@B28]; [@B38]). LncRNAs do not encode proteins but regulate gene expression through epigenetic, transcriptional and post-transcriptional regulation mechanisms ([@B28]). LncRNAs can fold into secondary or higher order structures to more flexibly target proteins or gene sites ([@B22]). LncRNAs exert critical roles on regulating biological processes such as cell survival, cell cycle, and metabolism ([@B26]; [@B21]). Endothelial cells, vascular smooth muscle cells and macrophages are the primary cells leading to atherosclerotic lesion formation ([@B53]). Previous studies have demonstrated that lncRNAs regulate the functions of endothelial cells, smooth muscle cells and macrophages, suggesting that lncRNAs are emerging important players in the progression of atherosclerosis ([@B28]; [@B59]). However, the underlying mechanisms of lncRNAs in CIH aggravating atherosclerosis are poorly understood, and the study of lncRNAs in CIH aggravating atherosclerosis is scarce.

In the present study, we analyzed lncRNAs and mRNAs by microarray at different time points during the atherosclerosis process in ApoE-deficient mice fed a high-fat diet under CIH or normoxia conditions. We performed a systematic analysis of the functionality of lncRNAs and mRNAs during the progression of atherosclerosis under CIH exposure. These findings will shed new light on the roles of OSA and CIH on atherosclerosis.

Materials and Methods {#S2}
=====================

Animals {#S2.SS1}
-------

Male 8-week-old ApoE^--/--^ mice were purchased from Beijing Hua Fukang Biotechnology, Co. Ltd. (Beijing, China). The ApoE^--/--^ mice were randomly divided into five groups: Nor 8W (mice in normoxia for 8 weeks), CIH 8W (mice in CIH for 8 weeks), Nor 12W (mice in normoxia for 12 weeks), CIH 12W (mice in CIH for 12 weeks), and CIH 8W + Nor 4W groups (mice in CIH for 8 weeks followed by normoxia for 4 weeks). All ApoE^--/--^ mice were fed with high-fat feed (21% fat and 0.15% cholesterol), which was purchased from Beijing Hua Fukang Biotechnology, Co. Ltd. The aorta from the five groups (5 in Nor 8W, 5 in CIH8W, 5 in Nor 12W, 4 in CIH 12W, 4 in CIH 8W + Nor 4W) was used for microarray analysis. All animal procedures conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication no. 85-23, revised 1996). This study was approved by the Institutional Animal Care and Use Committee of Capital Medical University, Beijing, China.

Intermittent Hypoxia {#S2.SS2}
--------------------

ApoE^--/--^ mice were placed into a plexiglass chamber connected to OxyCycler A84 (BioSpherix, Redfield, NY, United States). During each period of intermittent hypoxia, the fractional inspired O~2~ (FiO~2~) was reduced from 20.9 to 5.0--6.0% over 120 s and re-oxygenated to 20.9% in the subsequent 60 s period. This cycle was repeated every 180 s from 09:00 to 21:00 daily to coincide with mouse sleep cycles. Normoxia was delivered at identical flow rates with a constant FiO~2~ of 20.9%.

Atherosclerotic Lesion Analysis {#S2.SS3}
-------------------------------

The day following the last exposure period, ApoE^--/--^ mice were intraperitoneally administered 1% pentobarbital sodium anesthesia (5 mg/kg). Mice were sacrificed and transcardially perfused with PBS. For analysis of atherosclerotic lesions on aorta, the aortic tree was opened longitudinally starting from the aortic root to the iliac bifurcation, pinned, fixed in 10% buffered formalin, and stained with Oil Red O. The atherosclerotic burden was quantified in a blind fashion using NIS-Elements F Ver4.60.00 software (Nikon, Tokyo, Japan) and expressed as the ratio of Oil Red O-positive lesions to the total aortic area.

Total RNA Extraction {#S2.SS4}
--------------------

Total RNA was extracted from mouse aorta using TRIZOL reagent (Life Technologies, Foster City, CA, United States) following the manufacturer's instructions, and digested with DNase I at 37°C for 15 min to remove any contaminating DNA. The RNA was further purified with the RNeasy Kit (Qiagen, Hilden, Germany). The RNA quantity and quality were measured by a NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, United States), and the RNA integrity was assessed by standard denaturing agarose gel electrophoresis.

Microarray Analysis {#S2.SS5}
-------------------

The transcriptome was analyzed using the Clariom^TM^ D Array (Mouse; Affymetrix, Thermo Fisher Scientific), which contains transcripts of 22413 coding RNAs and 43543 non-coding RNAs. The RNA labeling and microarray hybridization were carried out according to the GeneChip WT PLUS Reagent Kit User Guide (P/N 703174 Rev.5, Affymetrix, Inc., Santa Clara, CA, United States). Briefly, the total RNA was amplified and transcribed into cRNA along the entire length of the transcripts without 3′ bias. The sense-strand cDNA was synthesized by reverse transcription of cRNA. The sense-strand cDNA was fragmented and labeled with biotin. The sense-strand cDNA was hybridized to the Clariom^TM^ D Array at 45°C for 16 h according to the manufacturer's instructions. After hybridization, the microarrays were washed and then stained in Affymetrix Fluidics Station 450 (Affymetrix) and scanned using theGene-Chip^®^ scanner 3000 7G (Affymetrix) following the manufacturer's instructions. Affymetrix^®^ GeneChip Command Console (AGCC) was used to analyze acquired array images. Raw signal intensities were normalized using Transcriptome Analysis Console (TAC) 4.0 software (Applied Biosystems, Thermo Fisher Scientific). Microarray data were deposited in NCBI with the GEO accession code [GSE145221](GSE145221).

Quantitative Real-Time PCR {#S2.SS6}
--------------------------

Microarray data were validated by qRT-PCR. In brief, total RNA was extracted by TRIZOL reagent (Life Technologies, Thermo Fisher Scientific) and purified with the RNeasy Kit (Qiagen) according to the manufacturer's instructions. M-MLV reverse transcription was used to synthesize cDNA (Promega, Madison, WI, United States). Quantitative real-time PCR was carried out with SYBR Green PCR mix (Applied Biosystems) on the ABI 7900HT qPCR system (Applied Biosystems). Four mRNAs and two lncRNAs were randomly selected for validation. The following primers were used: Cox8b (5′-TGTGGGGATCTCAGCCATAGT-3′ forward; 5′-AGTGGGCTAAGACCCATCCTG-3′ reverse), Hsp90b1 (5′-GTTCGTCAGAGCTGATGATGAA-3′ forward; 5′-GCGTTTAACCCATCCAACTGAAT-3′ reverse), Ucp1 (5′-GTGAACCCGACAACTTCCGAA-3′ forward; 5′-TGCCAGG CAAGCTGAAACTC-3′ reverse), Nr1d2 (5′-CAGGAGGTG TGATTGCCTACA-3′ forward; 5′-GGACGAGGACTGGAAGC TATT-3′ reverse), Gm13910 (5′-ATCCGTCCTTCCTC ACTGGA-3′ forward; 5′-TGATTAGCATCGCAGAAGCG-3′ reverse), Gm5421 (5′-CGAGGACATGGGACGATCAG-3′ forward; 5′-AACGATTCCACCCACATCCC-3′ reverse). RPS18 (Cat. Number B661301, Sango Biotech, Shanghai, China) was used as the internal control. The relative expression was calculated using the 2^--Δ^ ^Δ^ ^CT^ method and RPS18 was used to normalize the quantitative real-time data. Results were expressed as relative fold changes compared with levels in Nor 8W. After normalized microarray data as relative fold changes compared with levels in Nor 8W, Pearson's correlation coefficient was further calculated for each gene to quantify the consistency between microarray data and qRT-PCR data.

Bioinformatics Data Analysis {#S2.SS7}
----------------------------

After normalization of the raw data, we used the limma R package (version: 3.36.5) to filter the differentially expressed genes. Limma R used moderated F-statistic to filter the multi-group differentially expressed genes. Empirical Bayes moderation was used to correct the *p*-values ([@B43]). The threshold set for up- and down-regulated genes was a fold change \> 1.1 and *p* \< 0.05. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were used to investigate the roles of the differentially expressed mRNAs. The roles of the differentially expressed lncRNAs were investigated by KEGG pathway annotations of co-localized mRNAs and co-expressed mRNAs. The neighboring (20 kb upstream or downstream) protein-coding genes of the differentially expressed lncRNAs were selected as co-localized mRNAs. For GO analysis^[1](#footnote1){ref-type="fn"}^, the corresponding genes were divided into three aspects by enrichment analysis, including biological process (BP), molecular function (MF) and cellular component (CC). KEGG pathway analysis was performed to examine the significant pathways of the differentially expressed genes^[2](#footnote2){ref-type="fn"}^. The GO and KEGG pathway analysis were performed using R software with ggplot2 package. The mRNA-lncRNA co-expression network analysis was performed to assess functional annotation. The networks were built based on positive or negative correlations according to the normalized signal intensity of individual transcripts. The mRNAs and lncRNAs with significant differential expression between the five treatment groups were selected for the network analysis. The Pearson's correlation coefficient value was calculated for mRNA-lncRNA pairs. The strong correlated pairs (Pearson's correlation coefficient ≥ 0.9 and *p* \< 0.05) were selected for illustrating the co-expression network. Gene co-expression network was constructed from the preprocessed files using R package "weighted correlation network analysis" ([@B50]). Following the protocol for constructing gene co-expression network using multiple datasets ([@B51]), we first calculated Pearson correlation matrix for each dataset. We then obtained an overall weighted correlation matrix based on the number of samples used in that dataset. The visualization of network was built by software Cytoscape (version: 3.6.0).

Statistical Analysis {#S2.SS8}
--------------------

Data were expressed as means ± standard deviation. One-way ANOVA followed by Bonferronic *post hoc* test for comparisons between more than two groups was conducted in atherosclerotic lesion analysis. Limma R used moderated F-statistic to filter the multi-group differentially expressed genes. Empirical Bayes moderation was used to correct the *p*-values. GO analysis and pathway analysis were performed using the two side Fisher's exact test and Benjamini--Hochberg was used for multiple tests correction. Pearson's correlation coefficient was calculated to quantify the consistency between microarray data and qRT-PCR data. The differences were considered significant at *p* \< 0.05.

Results {#S3}
=======

CIH Exposure Aggravates Atherosclerosis in ApoE-Deficient Mice {#S3.SS1}
--------------------------------------------------------------

To observe atherosclerosis with CIH exposure, we fed ApoE-deficient mice with a high-fat diet under CIH or normoxia conditions. The atherosclerotic lesions of aorta were evaluated by Oil Red O staining ([Supplementary Figure S1](#FS1){ref-type="supplementary-material"}). After 8 weeks of a high-fat diet, there were few plaques in the aorta of ApoE-deficient mice in normoxia or CIH, and there was no significant difference in plaque area between these two groups. However, the plaque area of aorta in ApoE-deficient mice under CIH for 12 weeks was significantly increased (*p* \< 0.01) compared with ApoE-deficient mice in normoxia for 12 weeks. The plaque area of aorta in ApoE-deficient mice exposed to CIH for 8 weeks followed by normoxia for 4 weeks was significantly reduced (*p* \< 0.01) compared with ApoE-deficient mice under CIH for 12 weeks ([Supplementary Figure S1B](#FS1){ref-type="supplementary-material"}). These results indicate that long-term CIH exposure aggravates atherosclerosis.

Overview of Gene Expression {#S3.SS2}
---------------------------

We next performed gene expression analysis between mice in CIH or normoxia for various exposure times. The number of significantly up-regulated genes was higher than the number of significantly down-regulated genes in mice exposed to CIH for 8 weeks compared with mice under normoxia for 8 weeks ([Figure 1A](#F1){ref-type="fig"}). In contrast, the number of significantly down-regulated genes was higher than the number of up-regulated genes in mice in CIH for 12 weeks compared with mice in normoxia for 12 weeks or mice exposed to CIH for 8 weeks followed by normoxia for 4 weeks.

![mRNA and lncRNA gene expression analysis. **(A)** Total numbers of significantly differentially up-regulated and down-regulated probe sets in the indicated groups. **(B)** Venn diagrams depicting up-regulated and down-regulated mRNAs and lncRNAs in different comparison groups. The numbers of mRNAs and lncRNAs are indicated, and the common mRNAs and lncRNAs shared among all three comparison groups are listed.](fgene-11-00290-g001){#F1}

Analysis of significantly differentially expressed genes that were altered in the same direction in each of the three groups revealed overlapping genes. We identified 21 up-regulated lncRNAs in all three comparisons, and 8 down-regulated mRNAs and 16 down-regulated lncRNAs ([Figure 1B](#F1){ref-type="fig"}). The top 10 changed mRNAs are listed in [Table 1](#T1){ref-type="table"}. The information of all expressed mRNAs and lncRNAs is presented in [Supplementary Table S1](#TS1){ref-type="supplementary-material"}. Detailed information of differentially expressed mRNAs is presented in [Supplementary Table S2](#TS2){ref-type="supplementary-material"}, and detailed information of differentially expressed lncRNAs is presented in [Supplementary Table S3](#TS3){ref-type="supplementary-material"}.

###### 

The detailed information of the top 10 up-regulated and 10 down-regulated mRNAs.

  **CIH 8W vs. Nor 8W**   **gene_name**   **Fold change**   **CIH 12W vs. Nor 12W**   **gene_name**   **Fold change**   **CIH 12W vs. CIH 8W + Nor 4W**   **gene_name**   **Fold change**
  ----------------------- --------------- ----------------- ------------------------- --------------- ----------------- --------------------------------- --------------- -----------------
  Up-regulated            Igkv8-30        3.160             Up-regulated              Cry1            2.282             Up-regulated                      Arntl           3.434
                          Igkv4-91        2.998                                       Fos             2.204                                               Npas2           2.346
                          Spp1            2.717                                       2210407C18Rik   2.129                                               Cry1            2.313
                          Chil3           2.692                                       Angptl7         2.014                                               Hsph1           2.028
                          Ighv1-42        2.633                                       Gm13105         1.932                                               Creld2          1.919
                          Ighv14-4        2.582                                       Bmp3            1.932                                               Chil3           1.828
                          Ighv1-43        2.463                                       Hspb1           1.905                                               Nfil3           1.717
                          Igkv17-121      2.433                                       Nr4a1           1.866                                               Ccl7            1.682
                          Ighv1-31        2.429                                       Gm13295         1.853                                               Hspb1           1.647
                          Bcl2a1a         2.416                                       Hspa1a          1.84                                                Ptprz1          1.647
  Down-regulated          Cdr1            −1.459            Down-regulated            Npy             −3.945            Down-regulated                    Tef             −1.693
                          Dhcr24          −1.471                                      Mup1            −4.028                                              Bhlhe41         −2.028
                          Npy1r           −1.486                                      Gm2083          −4.084                                              Igkv12-46       −2.056
                          Pygm            −1.489                                      Mup19           −4.112                                              Per3            −2.173
                          Lgi1            −1.514                                      Gm10801         −4.141                                              Tcap            −2.828
                          Casq1           −1.516                                      Mup19           −4.141                                              Ciart           −3.317
                          Gldn            −1.518                                      Mup12           −4.257                                              Ucp1            −3.681
                          Sbspon          −1.549                                      Fabp7           −4.857                                              Nr1d2           −3.945
                          F830001A07Rik   −1.569                                      Snap25          −5.134                                              Dbp             −5.205
                          Fasn            −1.893                                      Dbh             −5.315                                              Nr1d1           −6.869

Validation of Microarray Data by qRT-PCR {#S3.SS3}
----------------------------------------

To validate the microarray results, four differentially expressed mRNAs (Cox8b, Nr1d2, Ucp1, Hsp90b1) and two differentially expressed lncRNAs (Gm13910 and Gm5421) were selected for qRT-PCR analysis in mouse aorta ([Figure 2](#F2){ref-type="fig"}). The expression levels detected by qRT-PCR were consistent with the microarray results, indicating that the microarray analysis was highly reliable.

![qRT-PCR validation of mRNA and lncRNA expression. Expression levels were determined by qRT-PCR analysis and the relative expression levels were calculated according to the 2^--\ Δ^ ^Δ^ ^Ct^ method using the RPS18 gene as an internal reference gene. qRT-PCR results are expressed as relative fold changes compared with Nor 8W. Microarray expression is also shown as relative fold changes compared with Nor 8W. R = Pearson correlation coefficient.](fgene-11-00290-g002){#F2}

Functional Annotation of Differentially Expressed mRNAs {#S3.SS4}
-------------------------------------------------------

To better understand the biological functions of mRNAs in atherosclerotic vascular tissue after exposure to CIH, we performed GO and KEGG pathway enrichment analysis on the mRNAs. GO analysis was performed on three different aspects including biological process (BP), cellular component (CC) and molecular function (MF) for up-regulated and down-regulated mRNAs ([Figure 3](#F3){ref-type="fig"} and [Supplementary Table S4](#TS4){ref-type="supplementary-material"}). The up-regulated mRNAs in the CIH 8W vs. Nor 8W comparison were genes involved in immune system process, inflammatory response and innate immune response ([Figure 3A](#F3){ref-type="fig"}), while the down-regulated mRNAs were associated with glutathione transferase activity, glutathione binding, and glutathione peroxidase activity ([Figure 3B](#F3){ref-type="fig"}). The up-regulated mRNAs in the CIH 12W vs. CIH 8W + Nor 4W comparison were genes involved in protein folding, protein transport and chaperone-mediated protein folding ([Figure 3E](#F3){ref-type="fig"}).

![Gene ontology (GO) analysis of differentially expressed mRNAs. GO annotation of up-regulated **(A)** and down-regulated **(B)** mRNAs in the CIH 8W vs. Nor 8W comparison. GO annotation of up-regulated **(C)** and down-regulated **(D)** mRNAs in the CIH 12W vs. Nor 12W comparison. GO annotation of up-regulated **(E)** and down-regulated **(F)** mRNAs in the CIH 12W vs. CIH 8W + Nor 4W comparison. Each color represents a different aspect. Only the top 10 GO terms are listed.](fgene-11-00290-g003){#F3}

KEGG pathway enrichment analysis demonstrated the possible involvement of significantly dysregulated mRNAs in related pathways and molecular interactions among genes. We identified some pathways with significant differences in mRNA expression ([Supplementary Table S5](#TS5){ref-type="supplementary-material"}). The top 10 most significant up-regulated and down-regulated pathway terms are shown in [Figure 4](#F4){ref-type="fig"}. The protein processing in endoplasmic reticulum was the most significant pathway within the set of up-regulated mRNAs in atherosclerotic vascular tissue of ApoE-deficient mice exposed to CIH for 12 weeks ([Figures 4C,E](#F4){ref-type="fig"}). The genes involved in the pathway of protein processing in endoplasmic reticulum were enriched and clustered for further analysis ([Figure 4G](#F4){ref-type="fig"}).

![KEGG signaling pathway analysis of differentially expressed mRNA. KEGG signaling pathways of up-regulated **(A)** and down-regulated **(B)** mRNAs in the CIH 8W vs. Nor 8W comparison. KEGG signaling pathways of up-regulated **(C)** and down-regulated **(D)** mRNAs in the CIH 12W vs. Nor 12W comparison. KEGG signaling pathways of up-regulated **(E)** and down-regulated **(F)** mRNAs in the CIH 12W vs. CIH 8W + Nor 4W comparison. Only the top 10 KEGG signaling pathways are listed. **(G)** Heatmap showing the differentially expressed genes in the pathway of protein processing in endoplasmic reticulum.](fgene-11-00290-g004){#F4}

Functional Annotation of Differentially Expressed LncRNAs {#S3.SS5}
---------------------------------------------------------

To better understand the function of the lncRNAs identified in our dataset, we assessed two aspects of the identified lncRNAs: (1) KEGG annotation of their co-localized mRNAs; (2) KEGG annotation of their co-expressed mRNAs. The neighboring (20 kb upstream or downstream) protein-coding genes of the differentially expressed lncRNAs were selected as co-localized mRNAs. There were some pathways with significant differences in lncRNA co-localized mRNAs expression ([Supplementary Table S6](#TS6){ref-type="supplementary-material"}). The top 10 most significant up-regulated and down-regulated pathway terms are shown in [Figure 5](#F5){ref-type="fig"}. The protein processing in endoplasmic reticulum was the overlapping pathway within the set of up-regulated lncRNA co-localized mRNAs in the CIH 12W vs. Nor 12W comparison and the CIH 12W vs. CIH 8W + Nor 4W comparison ([Figures 5C,E](#F5){ref-type="fig"}). We compared the co-localized mRNAs of the differentially expressed lncRNAs with differentially expressed mRNAs and listed the overlapped mRNAs in [Supplementary Table S7](#TS7){ref-type="supplementary-material"}.

![KEGG signaling pathway analysis of differentially expressed lncRNA co-localized mRNAs. KEGG signaling pathways of up-regulated **(A)** and down-regulated **(B)** lncRNA co-localized mRNAs in the CIH 8W vs. Nor 8W comparison. KEGG signaling pathways of up-regulated **(C)** and down-regulated **(D)** lncRNA co-localized mRNAs in the CIH 12W vs. Nor 12W comparison. KEGG signaling pathways of up-regulated **(E)** and down-regulated **(F)** lncRNA co-localized mRNAs in the CIH 12W vs. CIH 8W + Nor 4W comparison. Only the top 10 KEGG signaling pathways are listed.](fgene-11-00290-g005){#F5}

We also identified some pathways with significant differences in lncRNA co-expressed mRNAs expression ([Supplementary Table S8](#TS8){ref-type="supplementary-material"}). The top 10 most significant up-regulated and down-regulated pathway terms were shown in [Figure 6](#F6){ref-type="fig"}. The protein processing in endoplasmic reticulum was the overlap pathway within the set of up-regulated lncRNA co-expressed mRNAs in CIH 12W vs. Nor 12W comparison group and CIH 12W vs. CIH 8W + Nor 4W comparison group ([Figures 6C,E](#F6){ref-type="fig"}).

![KEGG signaling pathway analysis of differentially expressed lncRNA co-expressed mRNAs. KEGG signaling pathways of up-regulated **(A)** and down-regulated **(B)** lncRNA co-expressed mRNAs in the CIH 8W vs. Nor 8W comparison. KEGG signaling pathways of up-regulated **(C)** and down-regulated **(D)** lncRNA co-expressed mRNAs in the CIH 12W vs. Nor 12W comparison. KEGG signaling pathways of up-regulated **(E)** and down-regulated **(F)** lncRNA co-expressed mRNAs in the CIH 12W vs. CIH 8W + Nor 4W comparison. Only the top 10 KEGG signaling pathways are listed.](fgene-11-00290-g006){#F6}

We analyzed the relationship between differentially expressed mRNAs and lncRNAs, and listed mRNAs and lncRNAs with both co-localization and co-expression relationships in [Table 2](#T2){ref-type="table"}.

###### 

The detailed information of mRNAs and lncRNAs with both co-localization and co-expression relationships.

                        **mRNA\_ name**   **mRNA fold change**   **mRNA\_ chr**   **mRNA\_ start**   **mRNA\_ end**   **lncRNA\_ name**   **lncRNA fold change**   **lncRNA\_ chr**   **lncRNA\_ start**   **lncRNA\_ end**   **Relation**   ***p*-value**   **Regulation**
  --------------------- ----------------- ---------------------- ---------------- ------------------ ---------------- ------------------- ------------------------ ------------------ -------------------- ------------------ -------------- --------------- ----------------
  CIH 8W vs. Nor 8W     Cdr1              −1.459                 chrX             61183246           61185558         KnowTID_00007912    −1.184                   chrX               61187019             61189437           0.98           6.601E-07       Positive
                        Il2rg             1.609                  chrX             101264378          101268255        NONMMUT073343       1.384                    chrX               101264111            101268294          0.982          4.674E-07       Positive
                        Prg4              2.14                   chr1             150449412          150466165        NONMMUT003096       1.796                    chr1               150453960            150456397          0.983          3.45E-07        Positive
  CIH 12W vs. Nor 12W   Tubb1             −2.114                 chr2             174450595          174458380        NONMMUT041650       −2.585                   chr2               174458492            174459356          0.997          3.404E-09       Positive

Construction of the mRNA-LncRNA Co-expression Network {#S3.SS6}
-----------------------------------------------------

We then constructed the mRNA-lncRNA co-expression network based on the microarray results. A total 380 lncRNAs and 508 mRNAs containing 3238 relationships were selected to generate a network map ([Figure 7A](#F7){ref-type="fig"}). We identified three core mRNA-lncRNA regulation sub-networks during the process of atherosclerosis exposure to CIH. These sub-networks suggested a complex regulatory relationship between lncRNAs and mRNAs. One lncRNA could regulate multiple mRNAs in different ways, while one mRNA could be regulated by multiple lncRNAs. One sub-network containing 22 lncRNAs and 55 mRNAs is presented in detail in [Figure 7B](#F7){ref-type="fig"}. From the sub-network we found that cytochrome c oxidase subunit 8B (Cox8b), cytochrome c oxidase subunit 7A1 (Cox7a1) and cell death inducing DFFA like effector a (Cidea) were intimately related with lncRNAs Gm12251, Gm5421, Gm13910, and KnowTID_00004506. These mRNAs and lncRNAs were enriched and clustered for further analysis ([Figure 7C](#F7){ref-type="fig"}).

![Construction of the mRNA-lncRNA co-expression network. The network represents co-expression correlations between mRNAs and lncRNAs. In the network, circles represent mRNAs and squares represent lncRNAs. Black lines indicate co-expression regulation. The size of circle represents the number of genes in the network that interact with the mRNA, and the size of square represents the number of genes in the network that interact with the lncRNA. **(A)** A total 380 lncRNAs and 508 mRNAs containing 3238 relationships were selected to generate a total network map. **(B)** One sub-network from the blue frame in **(A)** is presented in detail. **(C)** Heatmap showing the differentially expressed mRNAs and lncRNAs from the blue frame in **(B)**.](fgene-11-00290-g007){#F7}

Discussion {#S4}
==========

Obstructive sleep apnea causes multiple physiological perturbations, among which CIH, long-term exposure to repeated episodes of hypoxia followed by reoxygenation is considered a prominent feature of OSA pathophysiology ([@B49]). In patients with severe OSA, these repeated episodes of hypoxia and reoxygenation can last for many years with hemoglobin desaturation to a level as low as 50% ([@B17]; [@B16]). In our study, we found that long-term CIH exposure aggravated atherosclerosis in ApoE^--/--^ mice fed a high-fat diet, and CIH followed by normoxia exposure significantly reduced atherosclerosis in ApoE^--/--^ mice compared with mice consistently exposed to long-term CIH exposure ([Supplementary Figure S1](#FS1){ref-type="supplementary-material"}). These results are consistent with previous studies. [@B46] found that C57BL/6J mice exposed to both high-cholesterol diet (HCD) and CIH developed atherosclerotic lesions in the aortic origin and descending aorta, although mice exposed to CIH alone did not develop atherosclerotic lesions. CIH accelerated atherosclerotic plaque growth in ApoE^--/--^ mice fed a high-cholesterol diet ([@B29]; [@B12]). [@B1] fed ApoE^--/--^ mice a standard-chow diet and exposed them to CIH for 14 days; the authors found that CIH aggravated atherosclerosis more severely in 20-week-old mice compared with 15-week-old mice. Together these studies demonstrated that CIH facilitate atherosclerosis or promote the progression of preexisting atherosclerosis.

Microarray technology enables quick and efficient exploration and identification of expression differences in various biological conditions. In this study, we investigated the mRNAs and lncRNAs in atherosclerotic vascular tissue to explore the molecular mechanisms underlying CIH aggravating atherosclerosis. We found that the number of significantly up-regulated genes was high in mice exposed to CIH for 8 weeks, while the number of significantly up-regulated genes was low in mice exposed to CIH for 12 weeks ([Figure 1A](#F1){ref-type="fig"}). This observation suggests that long-term CIH exposure can have a negative impact on the transcriptome and may lead to a decline in function in the atherosclerotic vascular tissue. To the best of our knowledge, this is the first study to investigate the potential role of differentially expressed mRNAs and lncRNAs in atherosclerotic vascular tissue of CIH exposure mice, and provide important clues to the mechanisms underlying OSA/CIH aggravates atherosclerosis in humans.

In this study, we found that Nr1d1 and Nr1d2 mRNAs were down-regulated in CIH 12W group compared with CIH 8W + Nor 4W group ([Table 1](#T1){ref-type="table"}). NR1D1 (REV-ERBα) and NR1D2 (REV-ERBβ) are members of the nuclear receptor (NR) superfamily and play important roles in the regulation of circadian rhythm, metabolism and immune function ([@B35]). Previous research have shown that hematopoietic knock down of NR1D1 increases atherosclerosis in LDL receptor knockout mice ([@B39]). SR9009, the synthetic REV-ERB agonist, reduced atherosclerotic plaque size in LDL receptor knockout mice ([@B48]). These researches demonstrated that REV-ERB (including NR1D1 and NR1D2) played an important role in atherosclerosis. Our results show that long-term CIH exposure resulted in decreased Rev-erb mRNA expression ([Table 1](#T1){ref-type="table"}) and increased atherosclerosis ([Supplementary Figure S1](#FS1){ref-type="supplementary-material"}), indicating that REV-ERB is likely to play an important role in CIH-aggravated atherosclerosis. Both mRNA Prg4 and lncRNA NONMMUT003096were up-regulated in CIH 8W group compared with Nor 8W ([Table 2](#T2){ref-type="table"}). Previous research show the Prg4 expression was increased in murine initial atherosclerotic lesions, and deletion of Prg4 in macrophage had effect on both cellular cholesterol metabolism and inflammation *in vitro* ([@B41]). Our results demonstrate that Prg4 and NONMMUT003096 had both co-localization and co-expression relationships. The function of NONMMUT003096 is not clear. The previous sequencing data showed that NONMMUT003096 was high expressed in the heart, and expressed in the spleen and lung, but not expressed in the thymus, liver, and hippocampus ([@B31]). Thus, Prg4 and NONMMUT003096 might have effect on macrophage function in CIH-aggravated atherosclerosis.

Long-term CIH exposure induced up-regulated mRNAs, lncRNA co-localized mRNAs and lncRNA co-expressed mRNAs were all enriched in the pathway of protein processing in endoplasmic reticulum ([Figures 4](#F4){ref-type="fig"}--[6](#F6){ref-type="fig"}). Many of the genes involved in this pathway are ultimately transcribed and translated into heat shock proteins (HSPs) such as HSP90, HSPa8, HSPa5 ([Figure 4G](#F4){ref-type="fig"}). HSPs are evolutionarily conserved and found in most prokaryotes and eukaryotes ([@B27]). HSPs are induced by physiological and environmental insults such as heat stress, nutritional deficiencies, hypoxia, chemical toxicity, or other types of stress ([@B7]). The main role of HSPs is to act as molecular chaperones that prevent protein misfolding and aggregation by facilitating protein folding and maintaining proper three-dimensional protein structure ([@B3]). HSPs not only maintain protein homeostasis, but also maintain cellular homeostasis through their anti-apoptotic effects ([@B25]). Previous research demonstrated that serum HSP70 (HSPA8) was significantly increased in OSA patients compared with control subjects ([@B23]). Gene expression analysis showed HSP70 was up-regulated in rat gastric epithelial cells under hypoxia-reoxygenation stimulation ([@B30]). Hypoxia, especially intermittent hypoxia, could induce GRP78 (HSPA5) high expression in aortic arch ([@B56]). The effects of HSPs on the development of atherosclerosis have been demonstrated in some studies. The inhibitors of HSP90 suppressed the migration of vascular smooth muscle cells and attenuated the formation of atherosclerotic plaques ([@B33]). HSP70 overexpression increased lipid accumulation in the arteries and promoted the formation of atherosclerotic lesions in ApoE-deficient mice ([@B58]). Here we demonstrated that long-term CIH exposure leads to increased expression of HSPs. Because HSPs are essential for the homeostasis of proteins and cells, they are likely to play important roles in CIH-aggravated atherosclerosis.

Brown adipose tissue (BAT) plays an important role in inhibiting atherosclerosis. From the lncRNA-mRNA co-expression sub-network ([Figure 7B](#F7){ref-type="fig"}), we found that Cox8b, Cox7a1 and Cidea were co-expressed with multiple lncRNAs, forming a complex network. Our results demonstrated that CIH leads to a decreased expression of brown adipocyte-selective genes Ucp1 ([Table 1](#T1){ref-type="table"}), Cox8b, Cox7a1 and Cidea ([Figure 7C](#F7){ref-type="fig"}). CIEDA were significantly down-regulated in atherosclerotic plaques of atherosclerotic patients compared with that in arteries of healthy control ([@B52]). UCP1 in BAT was significantly decreased after exposed to intermittent hypoxia ([@B15]). Perivascular adipose tissue (PVAT), which is defined as adipose tissue surrounding the blood vessels, is similar to classical BAT in rodents ([@B6]). Previous research has demonstrated that impaired PVAT is sufficient to drive increased atherosclerosis ([@B54]). BAT activation enhances energy expenditure and decreases plasma triglyceride and cholesterol levels, subsequently protecting against atherosclerosis development ([@B4]). Severe brown fat lipoatrophy aggravates the development of atherosclerosis, characterized by increased lipid depots, increases lesion size, and increases the inflammatory response ([@B20]). Our results indicated that CIH resulted in decreased browning of PVAT. The decreased browning of PVAT is likely to play an important function in CIH-aggravated atherosclerosis. Our results demonstrated that Cox8b, Cox7a1 and Cidea were intimately related with lncRNAs Gm12251, Gm5421, Gm13910, and KnowTID_00004506 ([Figure 7B](#F7){ref-type="fig"}). The effects of these lncRNAs are not clear. Gm12251 is NADH dehydrogenase (ubiquinone) Fe-S protein 3 pseudogene. Gm5421 is mitochondrial aconitase 2 pseudogene. Gm13910 is hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta pseudogene. These pseudogenes may have effects on regulating parent genes. The previous sequencing data showed that KnowTID_00004506 was not expressed in the heart, spleen, lung, liver, and hippocampus ([@B31]). As CIH decreased browning of PVAT, these co-expressed lncRNAs (Gm12251, Gm5421, Gm13910, and KnowTID_00004506) may play an important role in CIH aggravating atherosclerosis by regulating expression of Cox8b, Cox7a1, or Cidea. Further studies are needed to validate our findings and to understand the molecular mechanisms of specific lncRNAs implicated in CIH aggravating atherosclerosis.

Conclusion {#S5}
==========

Our study provided comprehensive analysis of the mRNA and lncRNA expression profiles in atherosclerotic aorta exposed to CIH. The integrated interpretation of differential mRNA and lncRNA expression reveals that long-term CIH induced the protein processing in endoplasmic reticulum pathway. HSPs and their functions in protein folding may play important roles in CIH aggravating atherosclerosis. We built a molecular interaction network with 380 lncRNAs, 508 mRNAs and 3238 relationships. To the best of our knowledge, this is the first study to investigate the potential role of differentially expressed mRNAs and lncRNAs in atherosclerotic vascular tissue of CIH exposure mice, and provide potential molecular candidates that might be important for future studies on the underlying mechanisms of CIH aggravating atherosclerosis.
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